Hepatitis Monthly

Published by: Kowsar

Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013

Masoumeh Moezzi 1 , Reza Imani 2 , * , Nasser Khosravi 2 , Behrouz Pourheidar 3 , Forouzan Ganji 1 and Ali Karimi 4
Authors Information
1 Department of Community Medicine, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
2 Department of Infectious Diseases, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
3 Central Disease Control Unit, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Department of Microbiology, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
Article information
  • Hepatitis Monthly: May 01, 2014, 14 (5); e17398
  • Published Online: May 3, 2014
  • Article Type: Research Article
  • Received: January 5, 2014
  • Revised: February 15, 2014
  • Accepted: March 24, 2014
  • DOI: 10.5812/hepatmon.17389

To Cite: Moezzi M, Imani R, Khosravi N, Pourheidar B, Ganji F, et al. Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013, Hepat Mon. 2014 ; 14(5):e17398. doi: 10.5812/hepatmon.17389.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003; 39 Suppl 1-9[PubMed]
  • 2. Pan CQ, Zhang JX. Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci. 2005; 2(1): 36-40[PubMed]
  • 3. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine. 1999; 17(13-14): 1730-3[PubMed]
  • 4. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 1988; 61(10): 1942-56[PubMed]
  • 5. Zali MR, Kazem M, Farhadi A, Masjedi MR, Zargar A, Nowroozi A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
  • 6. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980; 9(2): 144-8[PubMed]
  • 7. Ghavanini AA, Sabri MR. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East Mediterr Health J. 2000; 6(5-6): 1114-6[PubMed]
  • 8. Merat S, Malekzadeh R, Hoori R, Khatibian M. Hepatitis B in Iran. Arch Iran Med . 2000; 3(4): 192-201
  • 9. Alizadeh AH, Ranjbar M, Ansari S, MirArab A, Alavian SM, Mohammad K, et al. Seroprevalence of hepatitis B in Nahavand, Islamic Republic of Iran. East Mediterr Health J. 2006; 12(5): 528-37[PubMed]
  • 10. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008; 8(4): 281-94
  • 11. Khosravani A, Sarkari B, Negahban H, Sharifi A, Toori MA, Eilami O. Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran. BMC Infect Dis. 2012; 12: 378[DOI][PubMed]
  • 12. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prev Med. 2012; 3(11): 770-5[PubMed]
  • 13. Ansari-Moghaddam A, Ostovaneh MR, Sharifi Mood B, Sanei-Moghaddam E, Modabbernia A, Poustchi H. Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study. Hepat Mon. 2012; 12(9)[DOI][PubMed]
  • 14. Salehi M, Alavian SM, Tabatabaei SV, Izadi S, Sanei Moghaddam E, Amini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): 283-8[PubMed]
  • 15. Ghadir MR, Belbasi M, Heidari A, Jandagh M, Ahmadi I, Habibinejad H, et al. Distribution and risk factors of hepatitis B virus infection in the general population of Central Iran. Hepat Mon. 2012; 12(2): 112-7[DOI][PubMed]
  • 16. Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010; 28(3): 623-31[DOI][PubMed]
  • 17. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. Journal of Research in Medical Sciences. 2009; 14(4): 249-58[PubMed]
  • 18. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol. 2003; 38(4): 533-40[PubMed]
  • 19. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994; 23(3): 437-55[PubMed]
  • 20. Tavakkoli H, Mir-Nasseri MM, Poustchi H, Afshar P, Motalebi MN, Mohammadkhani A, et al. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002). Hepat Mon. 2008; 8(1): 29-33[DOI][PubMed]
  • 21. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B Prevalence and Risk Factors in Blood Donors in Ghazvin. Hepat Mon. 2005; 5(4): 117-22[DOI][PubMed]
  • 22. Nokhodian Z, Yazdani MR, Yaran M, Shoaei P, Mirian M, Ataei B, et al. Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran. Hepat Mon. 2012; 12(7): 442-7[DOI][PubMed]
  • 23. Qureshi H, Bile KM, Jooma R, Alam SE, Afridi HU. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J. 2010; 16 Suppl-23[PubMed]
  • 24. Ting-Lu Z, Zhi-Ping X, Hong-Yu L, Chang-Hong G, Liang Y, Qiang D, et al. A community-based sero-epidemiological study of hepatitis B infection in Lianyungang, China, 2010. Western Pac Surveill Response J. 2012; 3(3): 69-75[DOI][PubMed]
  • 25. Hong WW, Ang LW, Cutter JL, James L, Chew SK, Goh KT. Changing seroprevalence of hepatitis B virus markers of adults in Singapore. Ann Acad Med Singapore. 2010; 39(8): 591-8[PubMed]
  • 26. Ashraf H, Alam NH, Rothermundt C, Brooks A, Bardhan P, Hossain L, et al. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh. BMC Infect Dis. 2010; 10: 208[DOI][PubMed]
  • 27. Mikhailov MI, Mamedov MK, Dadasheva AE. [Comparative evaluation of prevalence of infections caused by hepatitis B and C viruses among individuals of various groups with high risk of infection]. Zh Mikrobiol Epidemiol Immunobiol. 2013; (4): 44-8[PubMed]
  • 28. Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3): 178-81[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments